Range of suitable people: CDEC talked over the uncertainty in the volume of people with reasonably critical to critical hemophilia B in Canada qualified for etranacogene dezaparvovec. Medical specialists consulted by CADTH indicated that some individuals who are categorised as owning delicate or rea